Věra Králová

842 total citations
28 papers, 683 citations indexed

About

Věra Králová is a scholar working on Molecular Biology, Oncology and Nutrition and Dietetics. According to data from OpenAlex, Věra Králová has authored 28 papers receiving a total of 683 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 7 papers in Oncology and 6 papers in Nutrition and Dietetics. Recurrent topics in Věra Králová's work include Selenium in Biological Systems (6 papers), Natural product bioactivities and synthesis (6 papers) and Cancer therapeutics and mechanisms (4 papers). Věra Králová is often cited by papers focused on Selenium in Biological Systems (6 papers), Natural product bioactivities and synthesis (6 papers) and Cancer therapeutics and mechanisms (4 papers). Věra Králová collaborates with scholars based in Czechia, Italy and Switzerland. Věra Králová's co-authors include Lenka Skálová, Veronika Hanušová, Emil Rudolf, Petra Matoušková, Martin Ambrož, Miroslav Červinka, Adam Skarka, Barbora Szotáková, Iva Boušová and Hana Svobodová and has published in prestigious journals such as International Journal of Molecular Sciences, Molecules and Experimental Cell Research.

In The Last Decade

Věra Králová

28 papers receiving 672 citations

Peers

Věra Králová

MB

ONCOL

FS

PS

CR

Alexandre F. Aissa Brazil

Benjaporn Buranrat Thailand

Ramakrishna Vadde India

Pin-Shern Chen Taiwan

Xiao Mou China

Shakti Prasad Pattanayak India

Juthika Kundu South Korea

Veronika Hanušová Czechia

Keiko Sakata Japan

Alexandre F. Aissa Brazil

Věra Králová

438 ×1.3

MB

122 ×1.0

ONCOL

52 ×0.6

FS

127 ×1.5

PS

143 ×1.7

CR

Citations per year, relative to Věra Králová Věra Králová (= 1×) peers Alexandre F. Aissa

Countries citing papers authored by Věra Králová

Since Specialization

Citations

This map shows the geographic impact of Věra Králová's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Věra Králová with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Věra Králová more than expected).

Fields of papers citing papers by Věra Králová

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Věra Králová. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Věra Králová. The network helps show where Věra Králová may publish in the future.

Co-authorship network of co-authors of Věra Králová

This figure shows the co-authorship network connecting the top 25 collaborators of Věra Králová. A scholar is included among the top collaborators of Věra Králová based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Věra Králová. Věra Králová is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Bezrouk, Aleš, Dana Čížková, Moustafa Elkalaf, et al.. (2022). The Effect of Chronic Exposure of Graphene Nanoplates on the Viability and Motility of A549 Cells. Nanomaterials. 12(12). 2074–2074. 4 indexed citations

2.

Milia, Egle, Marianna Usaï, Barbora Szotáková, et al.. (2020). The Pharmaceutical Ability of Pistacia lentiscus L. Leaves Essential Oil Against Periodontal Bacteria and Candida sp. and Its Anti-Inflammatory Potential. Antibiotics. 9(6). 281–281. 24 indexed citations

3.

Kubı́ček, Vladimı́r, Lenka Skálová, Adam Skarka, et al.. (2019). Carbonyl Reduction of Flubendazole in the Human Liver: Strict Stereospecificity, Sex Difference, Low Risk of Drug Interactions. Frontiers in Pharmacology. 10. 600–600. 5 indexed citations

4.

Skarka, Adam, et al.. (2019). The Evaluation of Glioblastoma Cell Dissociation and Its Influence on Its Behavior. International Journal of Molecular Sciences. 20(18). 4630–4630. 7 indexed citations

5.

Králová, Věra, et al.. (2018). Oxaliplatin and irinotecan induce heterogenous changes in the EMT markers of metastasizing colorectal carcinoma cells. Experimental Cell Research. 369(2). 295–303. 8 indexed citations

6.

Králová, Věra, et al.. (2018). Flubendazole and mebendazole impair migration and epithelial to mesenchymal transition in oral cell lines. Chemico-Biological Interactions. 293. 124–132. 24 indexed citations

7.

Hanušová, Veronika, Hana Svobodová, Martin Ambrož, et al.. (2017). The effects of β-caryophyllene oxide and trans-nerolidol on the efficacy of doxorubicin in breast cancer cells and breast tumor-bearing mice. Biomedicine & Pharmacotherapy. 95. 828–836. 68 indexed citations

8.

Ambrož, Martin, Iva Boušová, Adam Skarka, et al.. (2015). The Influence of Sesquiterpenes from Myrica rubra on the Antiproliferative and Pro-Oxidative Effects of Doxorubicin and Its Accumulation in Cancer Cells. Molecules. 20(8). 15343–15358. 61 indexed citations

9.

Hanušová, Veronika, Lenka Skálová, Věra Králová, & Petra Matoušková. (2015). Potential Anti-cancer Drugs Commonly Used for Other Indications. Current Cancer Drug Targets. 15(1). 35–52. 65 indexed citations

10.

Rudolf, Emil, et al.. (2013). The role of p38 in irinotecan-induced DNA damage and apoptosis of colon cancer cells. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 741-742. 27–34. 23 indexed citations

11.

Králová, Věra, et al.. (2013). Antiproliferative effect of benzimidazole anthelmintics albendazole, ricobendazole, and flubendazole in intestinal cancer cell lines. Anti-Cancer Drugs. 24(9). 911–919. 58 indexed citations

12.

Králová, Věra, et al.. (2011). Selenite-induced apoptosis and autophagy in colon cancer cells. Toxicology in Vitro. 26(2). 258–268. 32 indexed citations

13.

Hanušová, Veronika, et al.. (2010). The effectiveness of oracin in enhancing the cytotoxicity of doxorubicin through the inhibition of doxorubicin deactivation in breast cancer MCF7 cells. Xenobiotica. 40(10). 681–690. 15 indexed citations

14.

Králová, Věra, Miroslav Červinka, & Emil Rudolf. (2010). ROS mediate selenite-induced apoptosis in colon cancer cells. Open Life Sciences. 5(2). 166–177. 1 indexed citations

15.

Králová, Věra, et al.. (2009). Antiproliferative effects of selenium compounds in colon cancer cells: Comparison of different cytotoxicity assays. Toxicology in Vitro. 23(7). 1406–1411. 39 indexed citations

16.

Králová, Věra, et al.. (2009). Antiproliferative and cytotoxic effects of sodium selenite in human colon cancer cells. Toxicology in Vitro. 23(8). 1497–1503. 16 indexed citations

17.

Rudolf, Emil, et al.. (2008). Hexavalent chromium induces DNA damage and activates DNA-damage-response pathway in human skin cells. Toxicology Letters. 180. S114–S114. 2 indexed citations

18.

Rudolf, Emil, Věra Králová, & Miroslav Červinka. (2008). Selenium and Colon Cancer – From Chemoprevention to New Treatment Modality. Anti-Cancer Agents in Medicinal Chemistry. 8(6). 598–602. 10 indexed citations

19.

Rudolf, Emil, Věra Králová, & Miroslav Červinka. (2008). Selenium and Colon Cancer – From Chemoprevention to New Treatment Modality. Anti-Cancer Agents in Medicinal Chemistry. 8(6). 598–602. 7 indexed citations

20.

Sommer, A., et al.. (2000). Effective protein degradability and changes in amino acid spectrum after incubation of grains and mill feeds in rumen. Czech Journal of Animal Science. 45(8). 355–360. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact